<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Rogers Corporation — News on 6ix</title>
<link>https://6ix.com/company/rogers-corporation</link>
<description>Latest news and press releases for Rogers Corporation on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/rogers-corporation" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b9a378dffbe2df115899.webp</url>
<title>Rogers Corporation</title>
<link>https://6ix.com/company/rogers-corporation</link>
</image>
<item>
<title>Rogers Corporation Schedules First Quarter 2026 Earnings Call for April 28</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-first-quarter-2026-earnings-call-for-april-28</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-first-quarter-2026-earnings-call-for-april-28</guid>
<pubDate>Tue, 14 Apr 2026 20:05:00 GMT</pubDate>
<description>CHANDLER, Ariz., April 14, 2026--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce first quarter 2026 results on April 28, 2026 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Ali El-Haj, Interim President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financial Officer.</description>
</item>
<item>
<title>Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation</title>
<link>https://6ix.com/company/rogers-corporation/news/roche-expands-mass-spectrometry-menu-to-include-steroid-assays-receiving-clia-moderate-complexity-designation</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/roche-expands-mass-spectrometry-menu-to-include-steroid-assays-receiving-clia-moderate-complexity-designation</guid>
<pubDate>Wed, 18 Mar 2026 13:00:00 GMT</pubDate>
<description>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has categorized its Ionify® steroid assays for mass spectrometry as "moderate complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). This designation marks an important step toward expanding access to advanced diagnostic testing, which has historically been limited to highly specialized laboratories due to complex workflows and the need for expert operators.The Ionify® st</description>
</item>
<item>
<title>New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools</title>
<link>https://6ix.com/company/rogers-corporation/news/new-survey-demonstrates-how-diabetes-limits-day-to-day-freedom-for-people-around-the-world-and-highlights-need-for-predictive-tools-1</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/new-survey-demonstrates-how-diabetes-limits-day-to-day-freedom-for-people-around-the-world-and-highlights-need-for-predictive-tools-1</guid>
<pubDate>Thu, 05 Mar 2026 06:15:00 GMT</pubDate>
<description>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today findings from a global survey of 4,326 people with diabetes across 22 countries, exploring the logistical and emotional challenges they face in daily life.1 The survey highlights the unpredictable nature of living with diabetes and the multiple daily decisions that can make it difficult to plan ahead, with the majority (61%) of respondents reporting that they feel less confident that a day will go as planned. This is felt as a significant mental</description>
</item>
<item>
<title>Rogers Corporation Reports Fourth Quarter and Full Year 2025 Results</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-fourth-quarter-210400627</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-fourth-quarter-210400627</guid>
<pubDate>Tue, 17 Feb 2026 21:04:00 GMT</pubDate>
<description>CHANDLER, Ariz., February 17, 2026--Rogers Corporation (NYSE:ROG) today announced financial results for the full year and fourth quarter of 2025.</description>
</item>
<item>
<title>Rogers Corporation Schedules Fourth Quarter 2025 Earnings Call for February 17</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-fourth-quarter-210600693</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-fourth-quarter-210600693</guid>
<pubDate>Tue, 03 Feb 2026 21:06:00 GMT</pubDate>
<description>CHANDLER, Ariz., February 03, 2026--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce fourth quarter and full year 2025 results on February 17, 2026 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Ali El-Haj, Interim President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financial Officer.</description>
</item>
<item>
<title>Rogers Corporation Reports Third Quarter 2025 Results</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-third-quarter-200500737</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-third-quarter-200500737</guid>
<pubDate>Wed, 29 Oct 2025 20:05:00 GMT</pubDate>
<description>CHANDLER, Ariz., October 29, 2025--Rogers Corporation (NYSE:ROG) today announced financial results for the third quarter of 2025.</description>
</item>
<item>
<title>Rogers Corporation Announces Transition of Board Chair and Plans to Add New Independent Director</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-announces-transition-board-213100122</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-announces-transition-board-213100122</guid>
<pubDate>Thu, 16 Oct 2025 21:31:00 GMT</pubDate>
<description>CHANDLER, Ariz., October 16, 2025--Rogers Corporation (NYSE: ROG) (the "Company") today announced that Peter Wallace, Chair of the Board of Directors (the "Board"), has informed the Board of his decision not to stand for re-election at the Company’s 2026 Annual Meeting of Shareholders.</description>
</item>
<item>
<title>Rogers Corporation Schedules Third Quarter 2025 Earnings Call for October 29</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-third-quarter-200500536</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-third-quarter-200500536</guid>
<pubDate>Wed, 15 Oct 2025 20:05:00 GMT</pubDate>
<description>CHANDLER, Ariz., October 15, 2025--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2025 results on October 29, 2025 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Ali El-Haj, Interim President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financial Officer.</description>
</item>
<item>
<title>Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology</title>
<link>https://6ix.com/company/rogers-corporation/news/roches-elecsysr-ptau181-becomes-the-only-fda-cleared-blood-test-for-use-in-primary-care-to-rule-out-alzheimers-related-amyloid-pathology</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/roches-elecsysr-ptau181-becomes-the-only-fda-cleared-blood-test-for-use-in-primary-care-to-rule-out-alzheimers-related-amyloid-pathology</guid>
<pubDate>Mon, 13 Oct 2025 13:00:00 GMT</pubDate>
<description>Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181 test, the only blood-based biomarker (BBM) test indicated as an aid in the initial assessment for Alzheimer's disease and other causes of cognitive decline in the primary-care setting. The Elecsys pTau181 test is intended for patients ages 55 and older presenting with signs, symptoms or complaints of cognitive decline. It measures phosphorylated Tau (pTau)</description>
</item>
<item>
<title>Rogers Corporation Reports Second Quarter 2025 Results</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-second-quarter-201300215</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-second-quarter-201300215</guid>
<pubDate>Thu, 31 Jul 2025 20:13:00 GMT</pubDate>
<description>CHANDLER, Ariz., July 31, 2025--Rogers Corporation (NYSE:ROG) today announced financial results for the second quarter of 2025.</description>
</item>
<item>
<title>Rogers Corporation Schedules Second Quarter 2025 Earnings Call for July 31</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-second-quarter-210400988</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-second-quarter-210400988</guid>
<pubDate>Thu, 17 Jul 2025 21:04:00 GMT</pubDate>
<description>CHANDLER, Ariz., July 17, 2025--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce second quarter 2025 results on July 31, 2025 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Ali El-Haj, Interim President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financial Officer.</description>
</item>
<item>
<title>Rogers Corporation Announces CEO Transition</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-announces-ceo-transition-130000400</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-announces-ceo-transition-130000400</guid>
<pubDate>Mon, 14 Jul 2025 13:00:00 GMT</pubDate>
<description>CHANDLER, Ariz., July 14, 2025--The Board of Directors of Rogers Corporation (NYSE: ROG) today announced that Colin Gouveia has left his position as President and CEO and has resigned from the Board on July 12, 2025. Ali El-Haj has been named the company’s interim President and CEO. Mr. El-Haj brings global leadership experience in key Rogers markets and is well-positioned to advance the company’s strategic direction during this transition.</description>
</item>
<item>
<title>Rogers Corporation Reports First Quarter 2025 Results</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-first-quarter-200500866</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-first-quarter-200500866</guid>
<pubDate>Tue, 29 Apr 2025 20:05:00 GMT</pubDate>
<description>CHANDLER, Ariz., April 29, 2025--Rogers Corporation Reports First Quarter 2025 Results</description>
</item>
<item>
<title>Rogers Corporation Schedules First Quarter 2025 Earnings Call for April 29</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-first-quarter-200500033</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-schedules-first-quarter-200500033</guid>
<pubDate>Tue, 15 Apr 2025 20:05:00 GMT</pubDate>
<description>CHANDLER, Ariz., April 15, 2025--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce first quarter 2025 results on April 29, 2025 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financial Officer.</description>
</item>
<item>
<title>Rogers Corporation Reports Fourth Quarter and Full Year 2024 Results</title>
<link>https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-fourth-quarter-210500261</link>
<guid isPermaLink="true">https://6ix.com/company/rogers-corporation/news/rogers-corporation-reports-fourth-quarter-210500261</guid>
<pubDate>Wed, 19 Feb 2025 21:05:00 GMT</pubDate>
<description>CHANDLER, Ariz., February 19, 2025--Rogers Corporation (NYSE:ROG) today announced financial results for the full year and fourth quarter of 2024.</description>
</item>
</channel>
</rss>